Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
45 hedge funds and large institutions have $45.2M invested in Chembio diagnostics, Inc. in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 5 closing their positions.
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
18% more funds holding
Funds holding: 38 → 45 (+7)
2% more capital invested
Capital invested by funds: $44.2M → $45.2M (+$966K)
0.27% less ownership
Funds ownership: 42.28% → 42.02% (-0.27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
+$4.23M |
| 2 |
RA
Royce & Associates
New York
|
+$873K |
| 3 |
RC
Roubaix Capital
Denver,
Colorado
|
+$600K |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$553K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$471K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$609K |
| 2 |
AIP
ARS Investment Partners
New York
|
-$371K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$324K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$298K |
| 5 |
Renaissance Technologies
New York
|
-$210K |
CEMI Hedge Fund Activity: Q3 2019 in Review
45 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q3 2019, worth a combined $45.2M — up 2.2% from $44.2M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CEMI positions and 5 closed out — a net gain of 8 holders — while 13 added to existing stakes and 9 trimmed.
The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $4.23M. The largest seller was Wexford Capital, exiting entirely with an estimated $609K sold.
- 45 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q3 2019, up from 38 in Q2 2019.
- Funds reported $45.2M of Chembio diagnostics, Inc. stock for Q3 2019, up 2.2% quarter-over-quarter.
- 13 funds opened new Chembio diagnostics, Inc. positions in Q3 2019 and 5 closed out, a net change of +8 holders.
- The largest Chembio diagnostics, Inc. buyer in Q3 2019 was Silvercrest Asset Management, an estimated $4.23M added.
- The largest Chembio diagnostics, Inc. seller in Q3 2019 was Wexford Capital, an estimated $609K sold.
Based on aggregated 13F filings for Q3 2019.